Oroboros Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-08. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Sarah Silvergleid | Director | Cambridge, MA |
| Raffaella Squilloni | Director | Cambridge, MA |
| Robert Alexander Wesselhoeft IV | Director | Cambridge, MA |
| Sarah Silvergleid | Executive Officer | Cambridge, MA |
| Raffaella Squilloni | Executive Officer | Cambridge, MA |
| Robert Alexander Wesselhoeft IV | Executive Officer | Cambridge, MA |